STRO Fair Value Estimate
$58.24
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Sutro Biopharma Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
STROUDS INC
Did you know?
Holds 3.8x more cash than debt — a strong balance sheet.
Current Price
—
GoodMoat Value
$58.24
Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
Sutro Biopharma Inc (STRO) Valuation
STRO Valuation Metrics
FCF$-178.93M
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →STRO Valuation & Fair Value Analysis
Sutro Biopharma Inc (STRO) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The GoodMoat Fair Value target for Sutro Biopharma Inc is $58.24.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Sutro Biopharma Inc's intrinsic value.